PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
AboutPricing
Disease Reportsappendicitis
MeSH D001064 - appendicitis
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
See list view
D005759:Gastroenteritis
55 Companies
7 Drugs
$
Success rate
D059413:Intraabdominal infections
85 Companies
24 Drugs
$
Success rate
D002429:Cecal diseases
0 Companies
0 Drugs
Success rate
D001064: 
Appendicitis
11 Companies
2 Drugs
$
Success rate
Events Timeline
Loading
Commercial
Company Name
Drug Name
Trade Name
Patent Expires
Approval Date
Revenue
Period
Amneal PharmaceuticalsMeropenem Meropenem  2016-04-12   
B. Braun MedicalMeropenem Meropenem  2015-04-30   
Daewoong PharmaceuticalMeropenem Meropenem  2015-12-18   
Eugia Pharma SpecialtiesMeropenem Meropenem  2017-03-27   
Gland PharmaMeropenem Meropenem  2016-06-08   
HospiraMeropenem Meropenem  2010-06-22   
HQ Specialty PharmaMeropenem Meropenem  2019-08-16   
MenariniMeropenem, Vaborbactam Vaborem  2018-11-20   
PfizerMeropenem Merrem  1996-06-21   
SandozMeropenem Meropenem  2011-03-29   
1
2
>
Clinical Trials
Historical Success Rate
Phase 1
67%
4/6
Phase 2
26%
6/23
Phase 3
67%
6/9
Approved: 1Overall Success rate: 12%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name
Phase 1
Phase 2
Phase 3
Phase 4
Drug Name
Pfizer
Meropenem
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use